Nailfold capillaroscopy for new interstitial pneumonia diagnosis
Part of Lungs & breathing, Skin clinical trials.
This trial tests if a special microscope exam of your nailfold blood vessels (capillaroscopy) can help doctors better understand new cases of interstitial pneumonia. It may help identify underlying conditions without starting certain treatments first.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Diagnosed with interstitial pneumonia in the last 6 months by a lung specialist
- Had a chest CT scan, lung function tests, and specific blood tests in the last 6 months
- Speak and understand French
- Have not had a nailfold capillaroscopy before
- No known connective tissue disease or high suspicion of it
- Not currently on steroids, immune-suppressing drugs, or anti-scarring drugs for your lungs
- Not pregnant or breastfeeding
- Able to give consent and not under legal guardianship
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with scarring lung disease (pulmonary fibrosis) in Ireland. It aims to better understand and care for the condition, especially in families. The study will look at medical data and may help improve diagnosis and treatment.
This study is testing a new way to track lung scarring (fibrosis) over time in people with conditions like IPF, other fibrotic lung diseases, or early signs of scarring. It might help doctors understand how the disease changes.
This study helps doctors identify early signs of lung scarring (fibrosis) in patients with autoimmune diseases like scleroderma, rheumatoid arthritis, and Sjögren's syndrome. By catching this early, researchers hope to better understand and treat these complications.
This study looks at whether a simple test called capillaroscopy (which examines tiny blood vessels in your fingernails) can help doctors better manage undifferentiated connective tissue disease. If you join, the test results will be used to guide your care, and researchers will see how it affects treatment decisions.
This study is testing a new way to speed up the diagnosis of interstitial lung disease (a group of lung scarring conditions). If you have symptoms or scan findings that suggest ILD but haven't been fully diagnosed yet, this trial may help you get a faster, clearer answer.
This research study tests new diagnostic methods to better identify and predict outcomes in interstitial lung disease (a group of lung conditions causing scarring and breathing problems). Researchers are looking for people with ILD or those exposed to pigeons, which can trigger a type of lung disease.
Hear when a new Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.